See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Arcadia Biosciences, Inc. (RKDA) - free report >>
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Arcadia Biosciences, Inc. (RKDA) - free report >>
Image: Shutterstock
New Strong Buy Stocks for October 25th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Arcadia Biosciences, Inc. (RKDA - Free Report) : This company which engaged in developing and commercializing agricultural products primarily in the United States, has seen the Zacks Consensus Estimate for its current year earnings increasing 47.5% over the last 60 days.
Arcadia Biosciences, Inc. Price and Consensus
Arcadia Biosciences, Inc. price-consensus-chart | Arcadia Biosciences, Inc. Quote
GH Research PLC (GHRS - Free Report) : This clinical-stage biopharmaceutical company, has seen the Zacks Consensus Estimate for its current year earnings increasing 28.3% over the last 60 days.
GH Research PLC Price and Consensus
GH Research PLC price-consensus-chart | GH Research PLC Quote
The Gap, Inc. : This premier international specialty retailer which offers a diverse range of clothing, accessories, and personal care products, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.1% over the last 60 days.
The Gap, Inc. Price and Consensus
The Gap, Inc. price-consensus-chart | The Gap, Inc. Quote
Rithm Capital Corp. (RITM - Free Report) : This company which provides capital and services to the real estate and financial services industries, has seen the Zacks Consensus Estimate for its current year earnings increasing 7.9% over the last 60 days.
Rithm Capital Corp. Price and Consensus
Rithm Capital Corp. price-consensus-chart | Rithm Capital Corp. Quote
Exscientia plc : This artificial intelligence-driven pharmatech company has seen the Zacks Consensus Estimate for its current year earnings increasing 6.5% over the last 60 days.
Exscientia PLC Sponsored ADR Price and Consensus
Exscientia PLC Sponsored ADR price-consensus-chart | Exscientia PLC Sponsored ADR Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.